Cargando…

External validation of prognostic models: what, why, how, when and where?

Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is nece...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramspek, Chava L, Jager, Kitty J, Dekker, Friedo W, Zoccali, Carmine, van Diepen, Merel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857818/
https://www.ncbi.nlm.nih.gov/pubmed/33564405
http://dx.doi.org/10.1093/ckj/sfaa188
_version_ 1783646518352281600
author Ramspek, Chava L
Jager, Kitty J
Dekker, Friedo W
Zoccali, Carmine
van Diepen, Merel
author_facet Ramspek, Chava L
Jager, Kitty J
Dekker, Friedo W
Zoccali, Carmine
van Diepen, Merel
author_sort Ramspek, Chava L
collection PubMed
description Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is necessary to determine a prediction model’s reproducibility and generalizability to new and different patients. Various methodological considerations are important when assessing or designing an external validation study. In this article, an overview is provided of these considerations, starting with what external validation is, what types of external validation can be distinguished and why such studies are a crucial step towards the clinical implementation of accurate prediction models. Statistical analyses and interpretation of external validation results are reviewed in an intuitive manner and considerations for selecting an appropriate existing prediction model and external validation population are discussed. This study enables clinicians and researchers to gain a deeper understanding of how to interpret model validation results and how to translate these results to their own patient population.
format Online
Article
Text
id pubmed-7857818
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78578182021-02-08 External validation of prognostic models: what, why, how, when and where? Ramspek, Chava L Jager, Kitty J Dekker, Friedo W Zoccali, Carmine van Diepen, Merel Clin Kidney J CKJ Reviews Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is necessary to determine a prediction model’s reproducibility and generalizability to new and different patients. Various methodological considerations are important when assessing or designing an external validation study. In this article, an overview is provided of these considerations, starting with what external validation is, what types of external validation can be distinguished and why such studies are a crucial step towards the clinical implementation of accurate prediction models. Statistical analyses and interpretation of external validation results are reviewed in an intuitive manner and considerations for selecting an appropriate existing prediction model and external validation population are discussed. This study enables clinicians and researchers to gain a deeper understanding of how to interpret model validation results and how to translate these results to their own patient population. Oxford University Press 2020-11-24 /pmc/articles/PMC7857818/ /pubmed/33564405 http://dx.doi.org/10.1093/ckj/sfaa188 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle CKJ Reviews
Ramspek, Chava L
Jager, Kitty J
Dekker, Friedo W
Zoccali, Carmine
van Diepen, Merel
External validation of prognostic models: what, why, how, when and where?
title External validation of prognostic models: what, why, how, when and where?
title_full External validation of prognostic models: what, why, how, when and where?
title_fullStr External validation of prognostic models: what, why, how, when and where?
title_full_unstemmed External validation of prognostic models: what, why, how, when and where?
title_short External validation of prognostic models: what, why, how, when and where?
title_sort external validation of prognostic models: what, why, how, when and where?
topic CKJ Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857818/
https://www.ncbi.nlm.nih.gov/pubmed/33564405
http://dx.doi.org/10.1093/ckj/sfaa188
work_keys_str_mv AT ramspekchaval externalvalidationofprognosticmodelswhatwhyhowwhenandwhere
AT jagerkittyj externalvalidationofprognosticmodelswhatwhyhowwhenandwhere
AT dekkerfriedow externalvalidationofprognosticmodelswhatwhyhowwhenandwhere
AT zoccalicarmine externalvalidationofprognosticmodelswhatwhyhowwhenandwhere
AT vandiepenmerel externalvalidationofprognosticmodelswhatwhyhowwhenandwhere